Follow the Prostatype Genomics AB stock price and the full insider trade history of the company, a listed equity based in Finland. Shares are listed on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, Prostatype Genomics AB has recorded 9 insider filings. Market capitalisation: €15.2m. The latest transaction was disclosed on 15 August 2026 (Purchase). Among the most active insiders: Michael Häggman. All data is accessible without an account.
9
Insider Decl.
n/a
Thresholds
€413,131
9 ops.
Buy Volume
n/a
n/a
Sell Volume
41Σ signal
Buys €413,131n/a Sells
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.